Latest News about NVO
Recent news which mentions NVO
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds
November 27, 2023
From MarketWatch
From Motley Fool
Could Ozempic Harm These 3 Medical Device Stocks?
November 25, 2023
From Motley Fool
Novo Nordisk's Wegovy Eyes Asian Market Debut Despite Supply Crunch
November 24, 2023
Tickers
NVO
From Benzinga
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
November 24, 2023
Tickers
NVO
From Benzinga
7 Stocks Set to Capitalize on the Coming Year-End Rally
November 24, 2023
From InvestorPlace
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
November 23, 2023
From Motley Fool
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
November 23, 2023
From Benzinga
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
November 22, 2023
From InvestorPlace
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
November 22, 2023
Tickers
NVO
From Benzinga
Ozempic's Surging Demand Has Novo Nordisk Restricting It In Europe, Plus An Older Generation Diabetes Drug: What's Next?
November 21, 2023
Tickers
NVO
From Benzinga
3 Consumer Goods Stocks That Will Define the Next Decade
November 21, 2023
From InvestorPlace
From Benzinga
Medicare’s exclusion of weight-loss drug coverage under fire
November 20, 2023
From MarketWatch
From Motley Fool
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
November 20, 2023
From Motley Fool
From Motley Fool
AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock
November 17, 2023
From Motley Fool
7 A-Rated Retirement Stocks for Your November Buy List
November 17, 2023
From InvestorPlace
Pharmaceutical Giant Eli Lilly Plans Expansion In Germany, Eyes Diabetes Drug Production: Report
November 16, 2023
From Benzinga
Better Growth Stock: Novo Nordisk vs. Eli Lilly
November 16, 2023
From Motley Fool
Why Eli Lilly Stock Flopped While the Market Popped Today
November 15, 2023
From Motley Fool
Ozempic Shortage Crisis - Germany Weighs Export Restrictions on Novo Nordisk's Drug
November 15, 2023
From Benzinga
Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds
November 14, 2023
From MarketWatch
Novo Nordisk's Ozempic Usage Suspended - Belgium Implements Temporary Ban Amid Medication Shortage
November 14, 2023
Tickers
NVO
From Benzinga
Wegovy's Sales Potential Could Go Far Beyond Just Weight-Loss Treatment
November 14, 2023
Tickers
NVO
From Motley Fool
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
November 14, 2023
From Motley Fool
Better Growth Stock: Pfizer vs. Novo Nordisk
November 14, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.